A Fragrance Powerhouse

With the acquisition of Kering Beauté, L'Oréal now controls one of the most formidable fragrance portfolios in the industry. Creed alone generates over $1 billion in annual sales, commanding premium positioning across ultra-luxury department stores, niche retailers, and digital channels. The three LVMH-level fashion licenses—Gucci, Balenciaga, and Bottega Veneta—collectively represent approximately $3.2 billion in annual prestige fragrance revenue. For L'Oréal, which already owns Yves Saint Laurent Beauté, Giorgio Armani, and Valentino Beauty, this consolidation elevates the company's fragrance revenue to an estimated $8.5 billion annually, positioning it as the undisputed fragrance leader globally, ahead of Coty and IFF.

The strategic timing cannot be overlooked. Mass fragrance has surged 15% year-over-year according to Circana data, while prestige fragrance growth has plateaued at 5%. Yet ultra-luxury fragrance—the segment L'Oréal is now doubling down on—continues to grow at double-digit rates. Creed's niche positioning and Gucci's brand cachet ensure that L'Oréal's fragrance empire spans from the aspirational prestige tier through to genuine ultra-luxury, capturing wallet share across demographics and geographies.

"L'Oréal is signaling that fragrance is the growth engine for luxury beauty in the next decade. This acquisition isn't about defending turf—it's about owning the entire mountain."

Industry Analyst

The Coty Fallout: 2028 License Cliff

Coty, the current license holder for Gucci fragrance, will lose that designation in 2028 when Kering's current agreement expires. This represents a $600 million revenue headwind for the company—equivalent to roughly 7% of Coty's total annual sales. While Coty still retains fragrance licenses for Calvin Klein, Chloe, and Marchesa, the loss of Gucci eliminates its most prestigious fashion partnership. The timing compounds Coty's existing challenges: new CEO Markus Strobel is currently undertaking a strategic review of the company's mass color cosmetics portfolio, including potential divestitures of CoverGirl, Rimmel, and Sally Hansen. Losing Gucci fragrance while divesting mass color brands would fundamentally reshape Coty from a diversified beauty conglomerate into a narrower, fragrance-focused player.

The 2028 license cliff creates an interesting dynamic for distribution. Sephora and Ulta, which have become primary distribution partners for Coty's prestige fragrance business, will need to negotiate directly with L'Oréal for continued Gucci fragrance supply. L'Oréal's distribution relationships differ materially from Coty's: L'Oréal has historically favored luxury department store partnerships (Saks Fifth Avenue, Harrods, Bloomingdale's) and has been more selective about mass channel distribution. Expect Gucci fragrance to become even more exclusive post-acquisition, with potential price increases and limited SKU rationalization.

L'Oréal's 2025 Acquisition Spree: A New Strategy

The Kering Beauté acquisition is not an isolated move. In 2025 alone, L'Oréal acquired Color Wow, a $200 million color cosmetics brand, and Medik8, a clinical skincare brand with strong digital distribution. These three acquisitions signal a clear strategic direction: L'Oréal is moving beyond its traditional prestige/luxury franchises into adjacent categories that command higher price points and direct consumer relationships. Color Wow brought innovative volumizing products and strong retail positioning. Medik8 brought regulated skincare and a DTC playbook that outperforms many of L'Oréal's owned brands online.

"The future of beauty M&A is about adjacent expansion, not just brand stacking. Medik8, Color Wow, and now Kering—each fills a specific gap in the portfolio."

Senior M&A Advisor, Beauty Sector

The Wellness & Longevity Play

What unites these acquisitions is a thematic pivot toward "beauty as wellness." Color Wow serves the "hair longevity" thesis. Medik8 is positioned as clinical skincare that slows aging at a cellular level. And Creed—historically a fragrance house—is increasingly marketed through a wellness lens, with scent therapeutics positioning. L'Oréal is clearly building toward a joint venture or internal division focused on "luxury, wellness, and longevity"—categories that command 40-50% higher price points than traditional beauty and attract affluent consumers willing to trade volume for efficacy.

This positioning also matters for distribution. Sephora will remain the primary retail channel, but expect L'Oréal to expand premium DTC capabilities through owned e-commerce platforms, potentially through Instagram Shopping and TikTok Shop integrations. The Medik8 acquisition unlocked digital native distribution capabilities that L'Oréal lacked; expect these playbooks to migrate across the portfolio.

Global Distribution Reshuffled

The acquisition reshuffles distribution across key geographies. In the Middle East—where both Gucci and Balenciaga fragrances are category drivers—L'Oréal will consolidate distribution previously split between Kering and its own infrastructure. In Asia, where Creed has experienced explosive growth (particularly in Japan and Korea), L'Oréal gains direct control of supply chain optimization. In North America, the acquisition gives L'Oréal more leverage in negotiations with Sephora and Ulta, which will depend on L'Oréal for Gucci franchise access.

The closing is expected H1 2026, with full integration targeted for Q3 2026. By the end of 2026, expect to see significant distribution announcements around Creed expansion into new channel partners and potential premium positioning for the LVMH licenses within Sephora's assortment. The competitive implications for Coty are severe; for L'Oréal, this is a defining move that cements its position as the global leader in prestige beauty for the next decade.